Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
Identifieur interne : 000059 ( France/Analysis ); précédent : 000058; suivant : 000060Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
Auteurs : Clive Ballard [Royaume-Uni] ; Stuart Isaacson [États-Unis] ; Roger Mills [États-Unis] ; Hilde Williams [États-Unis] ; Anne Corbett [Royaume-Uni] ; Bruce Coate [États-Unis] ; Rajesh Pahwa [États-Unis] ; Olivier Rascol [France] ; David J. Burn [Royaume-Uni]Source :
- Journal of the American Medical Directors Association [ 1538-9375 ] ; 2015.
English descriptors
- KwdEn :
- Accidental Falls (statistics & numerical data), Adult, Aged, Aged, 80 and over, Antiparkinson Agents (therapeutic use), Antipsychotic Agents (administration & dosage), Antipsychotic Agents (adverse effects), Drug Therapy, Combination, Edema (epidemiology), Female, Humans, Hypotension, Orthostatic (epidemiology), Infection (epidemiology), Male, Middle Aged, Parkinson Disease (complications), Parkinson Disease (drug therapy), Parkinson Disease (mortality), Piperidines (therapeutic use), Psychotic Disorders (drug therapy), Psychotic Disorders (etiology), Stroke (epidemiology), Thromboembolism (epidemiology), Urea (analogs & derivatives), Urea (therapeutic use).
- MESH :
- chemical , administration & dosage : Antipsychotic Agents.
- chemical , adverse effects : Antipsychotic Agents.
- chemical , analogs & derivatives : Urea.
- chemical , therapeutic use : Antiparkinson Agents, Piperidines, Urea.
- complications : Parkinson Disease.
- drug therapy : Parkinson Disease, Psychotic Disorders.
- epidemiology : Edema, Hypotension, Orthostatic, Infection, Stroke, Thromboembolism.
- etiology : Psychotic Disorders.
- mortality : Parkinson Disease.
- statistics & numerical data : Accidental Falls.
- Adult, Aged, Aged, 80 and over, Drug Therapy, Combination, Female, Humans, Male, Middle Aged.
Abstract
To establish the mortality risk and adverse events associated with the use of atypical antipsychotic medications in people with Parkinson disease psychosis (PDP) in a clinically defined trial cohort.
DOI: 10.1016/j.jamda.2015.06.021
PubMed: 26239690
Affiliations:
- France, Royaume-Uni, États-Unis
- Angleterre, Californie, Floride, Grand Londres, Kansas, Midi-Pyrénées, Occitanie (région administrative)
- Londres, Toulouse
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000397
- to stream PubMed, to step Curation: 000397
- to stream PubMed, to step Checkpoint: 000397
- to stream Ncbi, to step Merge: 001C66
- to stream Ncbi, to step Curation: 001C66
- to stream Ncbi, to step Checkpoint: 001C66
- to stream Main, to step Merge: 000690
- to stream Main, to step Curation: 000689
- to stream Main, to step Exploration: 000689
- to stream France, to step Extraction: 000059
Links to Exploration step
pubmed:26239690Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.</title><author><name sortKey="Ballard, Clive" sort="Ballard, Clive" uniqKey="Ballard C" first="Clive" last="Ballard">Clive Ballard</name><affiliation wicri:level="3"><nlm:affiliation>Wolfson Centre for Age-Related Diseases, King's College London, London, UK. Electronic address: clive.ballard@kcl.ac.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Wolfson Centre for Age-Related Diseases, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Isaacson, Stuart" sort="Isaacson, Stuart" uniqKey="Isaacson S" first="Stuart" last="Isaacson">Stuart Isaacson</name><affiliation wicri:level="2"><nlm:affiliation>Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Floride</region></placeName><wicri:cityArea>Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton</wicri:cityArea></affiliation></author><author><name sortKey="Mills, Roger" sort="Mills, Roger" uniqKey="Mills R" first="Roger" last="Mills">Roger Mills</name><affiliation wicri:level="2"><nlm:affiliation>ACADIA Pharmaceuticals, San Diego, CA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>ACADIA Pharmaceuticals, San Diego</wicri:cityArea></affiliation></author><author><name sortKey="Williams, Hilde" sort="Williams, Hilde" uniqKey="Williams H" first="Hilde" last="Williams">Hilde Williams</name><affiliation wicri:level="2"><nlm:affiliation>ACADIA Pharmaceuticals, San Diego, CA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>ACADIA Pharmaceuticals, San Diego</wicri:cityArea></affiliation></author><author><name sortKey="Corbett, Anne" sort="Corbett, Anne" uniqKey="Corbett A" first="Anne" last="Corbett">Anne Corbett</name><affiliation wicri:level="3"><nlm:affiliation>Wolfson Centre for Age-Related Diseases, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Wolfson Centre for Age-Related Diseases, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Coate, Bruce" sort="Coate, Bruce" uniqKey="Coate B" first="Bruce" last="Coate">Bruce Coate</name><affiliation wicri:level="2"><nlm:affiliation>ACADIA Pharmaceuticals, San Diego, CA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>ACADIA Pharmaceuticals, San Diego</wicri:cityArea></affiliation></author><author><name sortKey="Pahwa, Rajesh" sort="Pahwa, Rajesh" uniqKey="Pahwa R" first="Rajesh" last="Pahwa">Rajesh Pahwa</name><affiliation wicri:level="2"><nlm:affiliation>University of Kansas Medical Center, Kansas City, KS.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Kansas</region></placeName><wicri:cityArea>University of Kansas Medical Center, Kansas City</wicri:cityArea></affiliation></author><author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Pharmacology and Neurosciences, University UPS of Toulouse III, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Clinical Pharmacology and Neurosciences, University UPS of Toulouse III, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J" last="Burn">David J. Burn</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Neuroscience, Newcastle University, Newcastle, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Neuroscience, Newcastle University, Newcastle</wicri:regionArea><wicri:noRegion>Newcastle</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26239690</idno><idno type="pmid">26239690</idno><idno type="doi">10.1016/j.jamda.2015.06.021</idno><idno type="wicri:Area/PubMed/Corpus">000397</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000397</idno><idno type="wicri:Area/PubMed/Curation">000397</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000397</idno><idno type="wicri:Area/PubMed/Checkpoint">000397</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000397</idno><idno type="wicri:Area/Ncbi/Merge">001C66</idno><idno type="wicri:Area/Ncbi/Curation">001C66</idno><idno type="wicri:Area/Ncbi/Checkpoint">001C66</idno><idno type="wicri:Area/Main/Merge">000690</idno><idno type="wicri:Area/Main/Curation">000689</idno><idno type="wicri:Area/Main/Exploration">000689</idno><idno type="wicri:Area/France/Extraction">000059</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.</title><author><name sortKey="Ballard, Clive" sort="Ballard, Clive" uniqKey="Ballard C" first="Clive" last="Ballard">Clive Ballard</name><affiliation wicri:level="3"><nlm:affiliation>Wolfson Centre for Age-Related Diseases, King's College London, London, UK. Electronic address: clive.ballard@kcl.ac.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Wolfson Centre for Age-Related Diseases, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Isaacson, Stuart" sort="Isaacson, Stuart" uniqKey="Isaacson S" first="Stuart" last="Isaacson">Stuart Isaacson</name><affiliation wicri:level="2"><nlm:affiliation>Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Floride</region></placeName><wicri:cityArea>Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton</wicri:cityArea></affiliation></author><author><name sortKey="Mills, Roger" sort="Mills, Roger" uniqKey="Mills R" first="Roger" last="Mills">Roger Mills</name><affiliation wicri:level="2"><nlm:affiliation>ACADIA Pharmaceuticals, San Diego, CA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>ACADIA Pharmaceuticals, San Diego</wicri:cityArea></affiliation></author><author><name sortKey="Williams, Hilde" sort="Williams, Hilde" uniqKey="Williams H" first="Hilde" last="Williams">Hilde Williams</name><affiliation wicri:level="2"><nlm:affiliation>ACADIA Pharmaceuticals, San Diego, CA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>ACADIA Pharmaceuticals, San Diego</wicri:cityArea></affiliation></author><author><name sortKey="Corbett, Anne" sort="Corbett, Anne" uniqKey="Corbett A" first="Anne" last="Corbett">Anne Corbett</name><affiliation wicri:level="3"><nlm:affiliation>Wolfson Centre for Age-Related Diseases, King's College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Wolfson Centre for Age-Related Diseases, King's College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Coate, Bruce" sort="Coate, Bruce" uniqKey="Coate B" first="Bruce" last="Coate">Bruce Coate</name><affiliation wicri:level="2"><nlm:affiliation>ACADIA Pharmaceuticals, San Diego, CA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>ACADIA Pharmaceuticals, San Diego</wicri:cityArea></affiliation></author><author><name sortKey="Pahwa, Rajesh" sort="Pahwa, Rajesh" uniqKey="Pahwa R" first="Rajesh" last="Pahwa">Rajesh Pahwa</name><affiliation wicri:level="2"><nlm:affiliation>University of Kansas Medical Center, Kansas City, KS.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Kansas</region></placeName><wicri:cityArea>University of Kansas Medical Center, Kansas City</wicri:cityArea></affiliation></author><author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Pharmacology and Neurosciences, University UPS of Toulouse III, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Clinical Pharmacology and Neurosciences, University UPS of Toulouse III, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J" last="Burn">David J. Burn</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Neuroscience, Newcastle University, Newcastle, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Neuroscience, Newcastle University, Newcastle</wicri:regionArea><wicri:noRegion>Newcastle</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of the American Medical Directors Association</title><idno type="eISSN">1538-9375</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Accidental Falls (statistics & numerical data)</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antiparkinson Agents (therapeutic use)</term><term>Antipsychotic Agents (administration & dosage)</term><term>Antipsychotic Agents (adverse effects)</term><term>Drug Therapy, Combination</term><term>Edema (epidemiology)</term><term>Female</term><term>Humans</term><term>Hypotension, Orthostatic (epidemiology)</term><term>Infection (epidemiology)</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (mortality)</term><term>Piperidines (therapeutic use)</term><term>Psychotic Disorders (drug therapy)</term><term>Psychotic Disorders (etiology)</term><term>Stroke (epidemiology)</term><term>Thromboembolism (epidemiology)</term><term>Urea (analogs & derivatives)</term><term>Urea (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antipsychotic Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Urea</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Piperidines</term><term>Urea</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term><term>Psychotic Disorders</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Edema</term><term>Hypotension, Orthostatic</term><term>Infection</term><term>Stroke</term><term>Thromboembolism</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Psychotic Disorders</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Accidental Falls</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To establish the mortality risk and adverse events associated with the use of atypical antipsychotic medications in people with Parkinson disease psychosis (PDP) in a clinically defined trial cohort.</div></front></TEI><affiliations><list><country><li>France</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Californie</li><li>Floride</li><li>Grand Londres</li><li>Kansas</li><li>Midi-Pyrénées</li><li>Occitanie (région administrative)</li></region><settlement><li>Londres</li><li>Toulouse</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Ballard, Clive" sort="Ballard, Clive" uniqKey="Ballard C" first="Clive" last="Ballard">Clive Ballard</name></region><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J" last="Burn">David J. Burn</name><name sortKey="Corbett, Anne" sort="Corbett, Anne" uniqKey="Corbett A" first="Anne" last="Corbett">Anne Corbett</name></country><country name="États-Unis"><region name="Floride"><name sortKey="Isaacson, Stuart" sort="Isaacson, Stuart" uniqKey="Isaacson S" first="Stuart" last="Isaacson">Stuart Isaacson</name></region><name sortKey="Coate, Bruce" sort="Coate, Bruce" uniqKey="Coate B" first="Bruce" last="Coate">Bruce Coate</name><name sortKey="Mills, Roger" sort="Mills, Roger" uniqKey="Mills R" first="Roger" last="Mills">Roger Mills</name><name sortKey="Pahwa, Rajesh" sort="Pahwa, Rajesh" uniqKey="Pahwa R" first="Rajesh" last="Pahwa">Rajesh Pahwa</name><name sortKey="Williams, Hilde" sort="Williams, Hilde" uniqKey="Williams H" first="Hilde" last="Williams">Hilde Williams</name></country><country name="France"><region name="Occitanie (région administrative)"><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000059 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000059 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= pubmed:26239690
|texte= Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i -Sk "pubmed:26239690" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |